Can a US doctor legally prescribe sermorelin today?

Yes, and a compounding pharmacy has a lawful basis to fill it, because sermorelin acetate was a component of an approved drug product, which is the mechanism section 503A provides. There is no marketed branded product to dispense, since Geref is discontinued with no current US label.

What tests will I need before a prescriber considers it?

Assessment of the growth hormone axis generally involves IGF-1 alongside growth hormone measurement, plus a full history. What is ordered and how it is interpreted is the prescriber's decision, and results usually take several days to come back.

Will insurance cover compounded sermorelin?

That depends on your plan, the indication and the pharmacy, and it varies enough that a general answer would mislead. Ask the pharmacy whether it bills insurance at all before assuming either way, because many compounding pharmacies are cash only.

Can I get a prescription through telehealth?

Often yes, with a blood draw you attend in person at a local laboratory. The trade is convenience against a subscription structure, so read the minimum term, the renewal terms and whether the prescription stays with you if you leave.

Why is a prescription possible for sermorelin but not for most research peptides?

Because it was an approved drug and they were not. That history is what section 503A works from, and it is also why sermorelin is absent from the FDA bulk substances risk list that names ibutamoren mesylate, ipamorelin acetate, GHRP-2 and GHRP-6.

Does having a prescription mean the treatment is well studied?

No, and the two should not be conflated. A prescription makes a purchase lawful and supervised. The literature for adult use remains thin, with zero registered trials naming the compound and a 2006 review paper that poses its central question rather than answering it.

How to Get Sermorelin Prescription Access, Explained

Summary: This is the one compound in this catalogue where the prescription route is real rather than theoretical. What makes it lawful, what a prescriber will want, and where the research vial honestly sits beside it.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

How to get sermorelin prescription access is a question that has a real answer, which is unusual for a compound sold in this market. Most of the peptides on the same catalogue pages have no lawful supervised route in the United States at all. This one does, and the reason traces back to a drug that was on American pharmacy shelves in the late 1990s.

That route is the subject of this page. The research vial is on the card below because it is one of the two things this search can mean, and it is not the one we would put first.

Where readers actually buy it

Ascension Peptides — Sermorelin

Research-grade Sermorelin, assayed by an outside lab and shipped from the US. The code below takes half off the vial.

Code at checkoutPEPTIDEDECK50% off

Sermorelin · 10 mg$72.00$36.00$3.60/mgGet the 10 mg →

The published certificate for lot 38-01260229 assays this vial at 11.31 mg against a 10 mg label, and reports purity and quantity only, with no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.

Batch certificate published for the lot
Free shipping over $250
Ships same day if ordered before 2pm CST

Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked September 6, 2026.

How to get sermorelin prescription access: why the route exists

Sermorelin was an approved American medicine. EMD Serono marketed it as Geref, under NDA 019863 for pituitary diagnostics, with submissions from 1991, and NDA 020443 for treatment, approved on 26 September 1997 ^[1]. Both applications now read Discontinued in FDA's records, and the same record carries the Federal Register determination that the product was not discontinued or withdrawn for safety or effectiveness reasons ^[1]. It left the market commercially, and there is no current US label.

Discontinuation of a branded product is not the end of access. Under section 503A a compounding pharmacy may work from a bulk drug substance that was a component of an approved drug product, even where no current monograph exists, and FDA sets out how the compounding provisions operate in its own questions and answers ^[2]. Sermorelin acetate was exactly such a component. That is the whole mechanism.

The contrast with its neighbours makes the point concrete. FDA maintains a list of bulk substances presenting significant safety risks. Ibutamoren mesylate sits on it under both 503A and 503B. Ipamorelin acetate, GHRP-2 and GHRP-6 sit on it. Kisspeptin-10 sits on it. BPC-157, Melanotan II, Selank acetate, Semax, MOTS-c, epitalon, CJC-1295, AOD-9604, GHK-Cu, LL-37, thymosin alpha-1 and the TB-4 fragment were nominated and then withdrawn ^[3]. Sermorelin appears in none of it, in any section, active or withdrawn, and never needed nominating.

What a prescriber will ask for

Expect a real consultation rather than a form that ends in a prescription.

A history. What prompted the visit, what symptoms you have, what medications you take, what your medical background is. Some of the questions will seem unrelated, because the prescriber is ruling conditions in and out rather than confirming the conclusion you arrived with.

Laboratory work. Assessment of the growth hormone axis generally involves IGF-1 measurement alongside growth hormone testing. Interpreting those results is the prescriber's job, and any page that tells you what your numbers should be is overstepping. Results take days. Our page on how a monitoring panel is used in supervised treatment gives a sense of how that kind of testing works in practice.

A reason to prescribe that they will write down. This is the part people underestimate. The approved indications were paediatric growth hormone deficiency and pituitary function testing. A request framed around adult vitality, sleep or body composition sits outside those, and a prescriber may decline. Being told no is a legitimate outcome of a consultation, not a failure of one.

A follow up plan. A prescriber who writes something and never sees you again has not really taken the case on.

What a compounding pharmacy will and will not fill

A 503A pharmacy compounds for an identified patient against a valid prescription. It is not a shop, and there is no walk in purchase.

Question to ask the pharmacy	Why it decides something
Do you compound sermorelin at all	Pharmacies differ, and a five minute call saves a wasted consultation fee
Will you accept a prescription from any licensed prescriber	Some pharmacies fill only for clinics they already work with, which quietly locks you into a programme
What is the fill price on its own	The only way to separate the medicine from the membership when a clinic quotes a bundle
What testing do you perform on the finished preparation	Pharmacy practice varies, and the assumption that everything is tested is not safe
How is it supplied and stored	Handling instructions come from the pharmacy, in writing, with the preparation

The pharmacy will not diagnose, will not decide the indication, and will not fill a request that arrives without a prescriber behind it. Those are features rather than obstacles: they are the controls that distinguish this route from a checkout page.

The cost, and the part we will not invent

We can give you exactly one column of costs honestly. The research vial on the card lists at $99.99, sells at $72.00 and comes to $36.00 with the code, which is $3.60 a milligram against the 10 mg label. The full arithmetic is on our sermorelin price page.

We do not publish figures for the prescription route. Pharmacy fill prices and clinic programme fees vary by pharmacy, by state and by what else is bundled into a visit, and we have no numbers we would stand behind. Anyone quoting you a national monthly figure for compounded sermorelin has estimated it.

What we can give you is a method. Ask for four numbers separately: the consultation, the laboratory panel, the pharmacy fill and any membership or subscription fee. Then compare programmes on those four numbers rather than on a headline monthly price. A clinic that refuses to break out the fill price is selling a bundle, and no per milligram figure will ever come out of a bundle. The channels are laid out side by side on where to buy sermorelin.

What the literature actually supports

This page would be dishonest if it made the prescription route sound like a well evidenced one. It is a lawful route. That is a different claim.

PubMed returns 332 papers mentioning sermorelin, three carrying the word in the title, and zero for sermorelin paired with anti ageing. ClinicalTrials.gov registers no studies naming the compound. A registry search appears to return results, but they are GHRH, tesamorelin and octreotide trials. Sermorelin is GHRH(1-29), so parts of the GHRH literature are genuinely adjacent, and adjacency is not the same as a trial of the compound in the vial.

Of the three title papers, one is a 1999 BioDrugs review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency ^[5], which is squarely the approved indication. Another, from 2006 in Clinical Interventions in Aging, asks in its own title whether sermorelin is a better approach to management of adult onset growth hormone insufficiency ^[4]. Note that it asks. A question in a title from 2006, with no registered trials in the two decades since, is the state of the adult literature.

So the honest summary is this: the compound is real, it was approved, the compounding route is lawful, and the adult use the market sells is not backed by a body of trials. A prescriber may still judge treatment appropriate, and that judgement is theirs to make and defend with a patient in front of them. It is not something a purchase page can do on their behalf.

Where the research vial honestly sits

If you have read this far and concluded the supervised route is what you want, the card at the top of this page is not for you, and we would rather say so than pretend otherwise.

If you are buying research material for laboratory work, the same discipline applies to the document rather than the prescriber. The listing linked here publishes a certificate from MZ Biolabs of Tucson, Arizona, for lot 38-01260229, analysed on 7 February 2026 by HPLC-UV-MS: 99.79 percent purity across four detected peaks, 11.31 mg measured against a 10 mg label, and a printed sequence that converts to the canonical 29 residue GHRH fragment. That certificate reports purity and quantity. It carries no endotoxin test and no sterility test, and scope is a property of the lot rather than of the vendor. The field by field reading is on sermorelin for sale.

We earn a commission if you use the link on the card. That is disclosed on the card and in our disclaimer, and it is exactly why the prescription route gets the top of this page and the card does not.

Common questions about getting a sermorelin prescription

Can a US doctor legally prescribe sermorelin today?: Yes, and a compounding pharmacy has a lawful basis to fill it, because sermorelin acetate was a component of an approved drug product, which is the mechanism section 503A provides. There is no marketed branded product to dispense, since Geref is discontinued with no current US label.
What tests will I need before a prescriber considers it?: Assessment of the growth hormone axis generally involves IGF-1 alongside growth hormone measurement, plus a full history. What is ordered and how it is interpreted is the prescriber's decision, and results usually take several days to come back.
Will insurance cover compounded sermorelin?: That depends on your plan, the indication and the pharmacy, and it varies enough that a general answer would mislead. Ask the pharmacy whether it bills insurance at all before assuming either way, because many compounding pharmacies are cash only.
Can I get a prescription through telehealth?: Often yes, with a blood draw you attend in person at a local laboratory. The trade is convenience against a subscription structure, so read the minimum term, the renewal terms and whether the prescription stays with you if you leave.
Why is a prescription possible for sermorelin but not for most research peptides?: Because it was an approved drug and they were not. That history is what section 503A works from, and it is also why sermorelin is absent from the FDA bulk substances risk list that names ibutamoren mesylate, ipamorelin acetate, GHRP-2 and GHRP-6.
Does having a prescription mean the treatment is well studied?: No, and the two should not be conflated. A prescription makes a purchase lawful and supervised. The literature for adult use remains thin, with zero registered trials naming the compound and a 2006 review paper that poses its central question rather than answering it.

The short version

The sermorelin prescription route exists because Geref was approved in 1997 and discontinued for commercial reasons rather than safety ones, which leaves a compounding pharmacy with a lawful basis under section 503A. Getting there means a prescriber, a history, growth hormone axis testing and a real possibility of being told no. Ask any pharmacy whether it compounds sermorelin and what the fill costs on its own, before a clinic wraps that number inside a membership. And keep the two claims separate: the route is lawful, and the adult use the market sells is not backed by trials.